It has been proposed that overexpression/amplification of HER2/neu (human epidermal growth factor-2) might pose a particular risk with an estimated 30-50% of advanced HER2-positive breast cancers progressing to brain metastases [21]. This evidence concerns the gene ERBB2 and breast cancer.